Review Identified Different Depression Treatment Targets in Alzheimer’s and Parkinson’s

Review Identified Different Depression Treatment Targets in Alzheimer's and Parkinson's

TL;DR: A 2026 narrative review in Molecular Psychiatry argues that depression in Alzheimer’s disease and Parkinson’s disease follows disease-specific brain mechanisms, while standard antidepressant evidence remains weak in these neurodegenerative populations. Key Findings 42% in Alzheimer’s disease: The review cites depressive syndromes affecting about 42% of patients with Alzheimer’s disease and 35% of patients with …

Read more

Tubulin Shifted Tau and Alpha-Synuclein Condensates Toward Microtubules

Tubulin Shifted Tau and Alpha-Synuclein Condensates Toward Microtubules

TL;DR: A 2026 study in Nature Communications reported that tubulin redirected Tau and alpha-synuclein condensates toward microtubule-building states, while tubulin loss pushed the same protein system toward toxic oligomers in cell models. Key Findings 36-hour shift: Tau and alpha-synuclein condensates formed stable high-molecular-weight oligomers and Tau:alpha-synuclein heterodimers after aging without tubulin. 10-micromolar tubulin: Adding tubulin …

Read more

Migrating Developing Neurons Generated Repairable DNA Breaks

Migrating Developing Neurons Generated Repairable DNA Breaks

TL;DR: A 2026 mouse and cell study in Nature found that developing neurons can generate DNA double-strand breaks while moving through narrow brain tissue during migration, then usually repair those breaks without cell death. Key Findings Developing neurons: The study tracked cerebellar granule neurons, Purkinje cells, and cortical neurons during normal brain development. Confined migration: …

Read more

Home Exercise Trial Will Test Parkinson Cognition and Biomarkers

Home Exercise Trial Will Test Parkinson Cognition and Biomarkers

TL;DR: A 2026 protocol in JMIR Research Protocols describes EXCEL-PD, a randomized trial testing whether 26 weeks of virtually supervised home endurance and resistance exercise is feasible, safe, and biologically informative for people with Parkinson disease. Key Findings Home trial design: EXCEL-PD randomizes 31 planned participants with Parkinson disease to home-based exercise or waitlist usual …

Read more

Karyoptosis Linked Proteotoxic Stress to Neurodegeneration

Karyoptosis Linked Proteotoxic Stress to Neurodegeneration

TL;DR: A 2026 study in Nature Communications found that proteotoxic stress can push neurons into karyoptosis, a cell-death pathway marked by nuclear lamina breakdown, nuclear-material expulsion, and dementia-linked tissue signatures. Key Findings Karyoptosis was induced by protein-clearance stress: Blocking autophagic lysosomal clearance caused LaminB1 disruption, nuclear-shape loss, cytoplasmic nuclear material, and later cell death. p38-LaminB1 …

Read more

Brain-Derived Plasma pTau217 Better Predicted Near-Term Amyloid PET Progression

Brain-Derived Plasma pTau217 Better Predicted Near-Term Amyloid PET Progression

TL;DR: A 2026 ADNI analysis posted to medRxiv found that brain-derived plasma pTau217 better predicted near-term amyloid positron emission tomography (PET) positivity than total plasma pTau217 in cognitively unimpaired amyloid-negative participants. Key Findings 1,427 ADNI participants: Plasma NULISAseq biomarkers were measured across the broader Alzheimer’s Disease Neuroimaging Initiative sample. 529 cognitively unimpaired: The main prognostic …

Read more

Diclofenac and Naproxen Use Linked to Lower Dementia Prevalence in NACC Cohort

Diclofenac and Naproxen Use Linked to Lower Dementia Prevalence in NACC Cohort

TL;DR: A 2026 retrospective analysis posted to medRxiv linked diclofenac and naproxen use in the NACC cohort to lower dementia and Alzheimer disease prevalence, while diclofenac use was also associated with slower Montreal Cognitive Assessment (MoCA) cognitive-screening decline. Key Findings NACC cohort: The analysis used 47,165 National Alzheimer’s Coordinating Center participants with data collected from …

Read more

Blood Transcriptomics Improved Parkinson Disease Classification vs Isolated RBD

Blood Transcriptomics Improved Parkinson Disease Classification vs Isolated RBD

TL;DR: A 2026 medRxiv preprint reported that peripheral blood RNA sequencing separated Parkinson disease from healthy controls and isolated REM sleep behavior disorder more clearly than it separated isolated REM sleep behavior disorder from controls. Key Findings 71 baseline samples: The main analysis included 20 healthy controls, 31 people with isolated REM sleep behavior disorder, …

Read more

Japan Dementia Specialist Survey Protocol Mapped Anti-Amyloid Antibody Bottlenecks

Japan Dementia Specialist Survey Protocol Mapped Anti-Amyloid Antibody Bottlenecks

TL;DR: A 2026 protocol posted to medRxiv describes a nationwide Japan survey designed to measure how dementia specialists handle anti-amyloid antibody therapy, biomarker testing, MRI safety monitoring, service capacity, and patient-choice tradeoffs. Key Findings Nationwide specialist survey: The protocol targets board-certified dementia specialists in Japan, especially physicians trained for anti-amyloid antibody therapy. June 2026 data …

Read more

Purkinje Cell Activity Poorly Predicted Cerebellar Output in Disease

Purkinje Cell Activity Poorly Predicted Cerebellar Output in Disease

TL;DR: A 2026 study in The Journal of Physiology found that steady-state Purkinje-cell firing patterns had limited ability to predict cerebellar nuclei output in mouse models of cerebellar movement disease. Key Findings 5 disease models: The reanalysis used in vivo recordings from mouse models involving ataxia, dystonia, tremor, and altered cerebellar circuitry. Purkinje-to-nuclei test: Researchers …

Read more